共 12 条
- [1] Doubleblind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Krum H,Sackner-berstein JD,Goldsmith RL,et al. Circulation . 1995
- [2] The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. Packer M. Journal of the American College of Cardiology . 1992
- [3] Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). MERIT-HF Study Group. The Lancet . 1999
- [4] 2000 Heart and stroke statistical update. American Heart Association. . 2000
- [5] Overview of randomized trials of angiotensinconverting enzyme inhibitors on mortality and morbidity in patients with heart failure. Garg R,Yusuf S. The Journal of The American Medical Association . 1995
- [6] Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beat-blocking agents. Bristow MR. The American Journal of Cardiology . 1993
- [7] Prospective randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms exercise ejection fraction and oxidative stress in heart failure. Kukin ML,Kalman J,Charney RH,et al. Circulation . 1999
- [8] Mechanism of action of beta-blocking agents in heart failure. Bristow MR. The American Journal of Cardiology . 1997
- [9] Plasma norepinephrine in congestive heart failure. Thomas JA,Marks BH. The American Journal of Cardiology . 1978
- [10] TheCardiac Insufficiency Bisoprolol Study Ⅱ( CIBIS-Ⅱ): a randomized trial. CIBIS-Ⅱ Investigators and Committees. The Lancet . 1999